Duloxetine Treatment for Postpartum Depression
Dr. Kimberly Yonkers
What is the purpose of this trial?
This is an open label treatment trial with the FDA approved medication Duloxetine to determine if this medication is equally effective as a treatment for women who have postpartum depression.
Study Status: Ongoing
Who can participate?
Gender Eligible: Female
Less than 6-months postpartum
Description of Trial:
Women are offered 12 weeks of medication treatment. The first 4 weeks are weekly visits, then bi-weekly and finally a monthly visit. Visits involve completing questionnaires about their medical history and symptoms, a brief physical exam and a psychiatric evaluation. Participants are also given a urine pregnancy test.
Treatment services are free and confidential and offered in English and Spanish at our New Haven, CT office. Participants are compensated up to $100.
Study HIC #: 06090001827
Please call 764-6764 to participate or click here for more information
Primary contact person is Heather Howell